Ranbaxy recalls

Ranbaxy has 9 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 12 Aug 2015. The most frequent reason is packaging defects.

Total recalls9since 2012
Last 12 months0reported
Class I00% of total
Ongoing0latest 12 Aug 2015

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 6 67%Class III 3 33%

Why ranbaxy is recalled

Product types

Brands

By year

All ranbaxy recalls, newest first

9 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAbsorica (isotretinoin) Capsules, 25 mg recalled by RanbaxyAbsorica LdRanbaxyLabeling ErrorsNationwide
DrugCLASS IIAtorvastatin Calcium Tablets recalled by RanbaxyAtorvastatin CalciumRanbaxyPackaging DefectsNationwide
DrugCLASS IIILac-Hydrin (ammonium lactate) Cream recalled by RanbaxyRanbaxyPackaging DefectsNationwide
DrugCLASS IIILac-Hydrin (ammonium lactate) Lotion recalled by RanbaxyRanbaxyPackaging DefectsNationwide
DrugCLASS IIAtorvastatin Calcium Tablets, 40 mg, a) per, b) recalled by RanbaxyAtorvastatin CalciumRanbaxyParticulate MatterNationwide
DrugCLASS IIAtorvastatin Calcium Tablets, 20 mg recalled by RanbaxyAtorvastatin CalciumRanbaxyParticulate MatterNationwide
DrugCLASS IIAtorvastatin Calcium Tablets, 10 mg recalled by RanbaxyAtorvastatin CalciumRanbaxyParticulate MatterNationwide
DrugCLASS IIAtorvastatin Calcium Tablets recalled by RanbaxyAtorvastatin CalciumRanbaxyPackaging DefectsNationwide
DrugCLASS IIIBalnetar Therapeutic Tar Bath, Coal Tar recalled by RanbaxyRanbaxyPotency & AssayNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.